Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone

Clinical and Experimental Metastasis

Volumn 15, Issue 4, 1997, Pages 400-409

  Rao, Velidi H ^a,b   Singh, Rakesh K ^b   Bridged, Julia A ^b   Neff, James R ^b   Schaefer, G Bradley ^a,b   Delimont, Duane C ^a   Dunn, Christopher M ^a   Sanger, Warren G ^a,b   Buehler, Bruce A ^a,b   Sawaya, Raymond ^d   Nicolson, Garth L ^c   Rao, Jasti S ^d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Institute for Molecular Medicine   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Cytokines; Giant cell tumor; Metalloproteinases; Stromal cells

Indexed keywords

EDETIC ACID; GELATINASE A; GELATINASE B;

ARTICLE; BONE TUMOR; CONTROLLED STUDY; GENE EXPRESSION; GENETIC REGULATION; GIANT CELL TUMOR; HUMAN; HUMAN CELL; STROMA CELL;

ADOLESCENT; BLOTTING, WESTERN; BONE NEOPLASMS; COLLAGENASES; CULTURE MEDIA, CONDITIONED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GIANT CELL TUMOR OF BONE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 8544229064     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018450204980     Document Type: Article

References (43)

1. Huvos A, 1991, Bone Tumors: diagnosis, treatment and prognosis. Philadelphia: WB Saunders Co, pp. 429-67.
2. McDonald D, Sim F, McLeod R and Dahlin D, 1986, Giant cell tumor of bone. J Bone Joint Surg, 68, 235-42.
3. Katz E, Nyska M, Okon E, Zajiak G and Robin G, 1987, Growth rate analysis of lung metastases from histologically benign giant cell tumor of bone. Cancer, 59, 1831-6.
4. Campanicci AM, 1993, Giant cell tumor of bone. Curr Orthopaedics, 7, 26-35.
5. Sung HW, Kuo DP, Shu WP, Chai Y and Lin C, 1982, Giant cell tumor of bone. Analysis of 208 cases in Chinese patients. J Bone Joint Surg, 64A, 755-61.
6. Komiya S, Inoue A, Nakashima M, Ueno A, Fujikawa K and Ikuta H, 1986, Prognostic factors in giant cell tumor of bone: a modified histological grading system useful as a guide to prognosis. Arch Orthop Trauma Surg, 105, 672.
7. Woessner JF, Jr, 1991, Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-54.
8. Stettler-Stevenson WG, 1990, Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev, 9, 289-303.
9. Matrisian LM, 1992, The matrix-degrading metalloproteinases. Bioessays, 14, 455-63.
10. Sasaguri Y, Kominya S, Sugama K, Suzuki K, Inoue A, Morimatsu M and Nagasi H, 1992, Production of matrix metalloproteinases 2 and 3 (slromelysin) by stromal cells of giant cell tumor of bone. Am J Pathol, 141, 611-21.
11. Rao VH, Bridge JA, Neff JR, et al. 1995, Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone. Clin Exp Metastasis, 13, 420-6.
12. Ueda Y, Imai K, Tsuchiya H, et al. 1996, Matrix metalloproteinase 9 (Gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am J Pathol, 148, 611-22.
13. Towbin H, Slaehlin T and Grodon J, 1979, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and applications. Proc Natl Acad Sci USA. 76, 4350-4.
14. Nakajima M, Welch DR, Belloni PN and Nicolson GL, 1987, Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adcnocarcinoma cell and clones differing metastatic potentials. Cancer Res, 47, 4869-76.
15. Onisto M, Garbisa S, Caenazzo C, et al. 1993, Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion. Diag Mol Pathol 2, 74-80.
16. Yamaguchi F, Saya H, Bruner JM and Morrison RS, 1994, Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA, 91, 484-8.
17. Hollister DW, Godfrey M, Sakai LY and Pyeritz RE, 1990, Immunohistologic abnormalities of the microfibrillar-fiber system in the marfan syndrome. N Engl J Med, 323, 152-9.
18. Schaefer GB and Godfrey M, 1995, Quantitation of fibrillin immunofluorescence in fibroblast cultures in the Marfan syndrome. Clin Genet, 47, 144-9.
19. Rock MG, Pritchard DJ and Unni KK, 1984, Metastasis from histologically benign giant-cell tumor of bone. J Bone Joint Surg, 66, 269-71.
20. Bertoni F, Present D, Sudanese A, Baldini N, Bacchini P and Campanacci M, 1988, Giant-cell tumor of bone with pulmonary metastases. Clin Orthop, 277, 275-85.
21. Goldring S, Schiller A, Mankin H, Dayer J and Krane S, 1986, Characterization of cells from human giant cell tumors of bone. Clin Orthop, 237, 275-285.
22. Campanacci M, Bagnara G, Serra M, Giovannini M, Pileri S and Poggi S, 1989, Giant cell tumor of bone: a model for the in vitro human osteoclast characterization. Tumorigenesis, 75, 389-95.
23. Huang TW, Green AD, Beattie CW and Das Gupta TK, 1993, Monocyte-macrophage-lineage of giant cell tumor of bone. Cancer, 71, 1751-60.
24. Horton MA, Lewis D, McNulty K, Pringle JAS and Chambers TJ, 1985, Monoclonal antibodies to osteoclastomas (giant cell tumors): definition of osteoclastspecific cellular antigen. Cancer Res, 45, 5663-9.
25. Wood GW, Neff JR, Gollahon KA and Gourley WK, 1978, Macrophages in giant cell tumors of bone. J Pathol, 124, 53-8.
26. Okada Y, Naka K, Kawamura K, et al. 1995, Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implication for bone resorption. Lab Invest, 72, 311-22.
27. Liotta LA, Steeg PS and Stettler-Stevenson WG, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-36.
28. Mignatti P and Rifkin DB, 1993, Biology and biochemistry of proteinases in tumor invasion. J Cell Physiol, 73, 161-95.
29. Tryggvason K, Hoyhtya M and Pyke C, 1993, Type IV collagenases in invasive tumors. Breast Cancer Res Treat, 24, 209-18.
30. Caballes RL, 1987, The mechanism of metastasis in the so-called "benign giant-cell tumor of bone". Hum Pathol, 79, 483-91.
31. Kanchisa J, Izumo T, Takeuchi M, Yamanaka T, Fuji T and Takeuchi H, 1991, In vitro bone resorption by isolated multinucleated giant cells from giant cell tumor of bone: light and electron microscopic study. Virchows Arch Pathol, 419, 327-38.
32. Goldberg GI, Strongin A, Collier IE, Genrich T and Marmer BL, 1992, Interaction of 92-kDa type IV collagenase with tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem, 267, 4583-91.
33. Bejarano PA, Noelken ME, Suzuki K, Hudson BG and Nagase H, 1988, Degradation of basement membrane by human matrix metalloproteinase 3 (stromelysin). Biochem J, 256, 413-19.
34. Van Der Zee E, Everts V, Hoeben K and Beertsen W, 1993, Interleukin-1α and epidermal growth factor synergistically enhance the release of collagenase by periostcal connective tissue in vitro. Matrix, 13, 389-98.
35. Galis ZS, Muszynski M, Sukhova GK, et al. 1994, Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix degradation. Circulation Res, 75, 181-9.
36. Delany AM and Brinckerhoff CE, 1992, Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J Cell Physiol, 50, 400-10.
37. Mizoguchi H, Komiyama S, Matsui K, et al. 1991, The response to epidermal growth factor of human maxillary tumor cells in terms of tumor growth, invasion and expression of proteinase inhibitors. Int J Cancer, 49, 738-43.
38. Yanagi H, Sasaguri Y, Sugama K, Morimatsu M and Nagase H, 1992, Production of tissue collagenase (Matrix metalloproleinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. Atherosclerosis, 91, 207-16.
39. Rawdanowicz TJ, Hampton AL, Nagase H, Woolley DE and Salamonsen LA, 1994, Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1a and tumor necrosis factor-α. J Clin Endocrinol Metab, 79, 530-6.
40. Westermarck J, Hakkinen L, Fiers W and Kahari V, 1995, TNF-R55-specilic form of human tumor necrosis factor-a induces collagenase gene expression by human skin fibroblasts. J Invest Dermatol, 105, 197-202.
41. Liesveld JL, Rush S, Kempski MC, et al. 1993, Phenotypic characterization of human fibrous histocytoma giant cell tumor (GCT) cell line and its cytokine repertoire. Exp Hematol, 21, 1342-52.
42. Kito M, Moriya H, Mikata A, et al. 1993, Establishment of a cell line from a human giant cell tumor bone. Clin Orthop Rel Res, 294, 353-60.
43. Keenan JA, Chen TT, Chadwell NL, Torry DS and Caudle MR, 1995, II-1 beta, TNF-alpha and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol, 34, 381-5.